Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections

E-ISSN： 1873-4286|21|28|4106-4111

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.28, 2015-08, pp. : 4106-4111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 5, 2016-12 ,pp. : 613-619

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic and prophylactic drugs to treat orthopoxvirus infections

By Parker Scott Handley Lauren Buller R Mark

Future Virology, Vol. 3, Iss. 6, 2008-11 ,pp. : 595-612

Future Medicine

Access to resources Recommend Favorite

Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

By Nicolau David P

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for bacterial urinary tract infections

By Wagenlehner Florian ME Weidner Wolfgang Naber Kurt G

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 275-298

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for bacterial urinary tract infections

By Wagenlehner Florian ME Weidner Wolfgang Perletti Gianpaolo Naber Kurt G

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 375-397

Informa Healthcare

Access to resources Recommend Favorite